Study of oral ASC36 for weight management in adults
Part of Hormones & metabolism clinical trials.
This study is testing an oral tablet (ASC36) to see if it is safe and how well it works for weight loss in adults who are overweight or have obesity. It is a first-in-human trial, so researchers are also studying how the body absorbs and processes the drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You do not smoke
- Your body mass index (BMI) is 27 or higher
- You are generally healthy, apart from being overweight or having obesity
- If you are a woman, you must not be pregnant, breastfeeding, or planning to become pregnant, and you must use highly effective birth control if you could become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injection called ASC36 in people who are overweight or have obesity, to see if it is safe, how the body processes it, and what effects it has. It may help with weight loss, but the main goal is safety.
This study tests a once-daily pill called ASC30 to help adults with obesity or overweight who also have conditions like high blood pressure, sleep apnea, or heart disease lose weight. The pill may work by affecting appetite and blood sugar, and the study aims to see how effective and safe it is.
This study tests a once-a-day pill for adults who are overweight or have obesity and also have type 2 diabetes. The goal is to see if the medication helps with weight loss and improves blood sugar control.
This study tests an injectable medication called ASC35 to see if it is safe and tolerable for people who are overweight or obese. It may help with weight management, though it is an early-stage trial focused on safety first.
This study tests a new weight-loss medicine called HRS-1596. It is given as a tablet to see if it is safe and how well it works. The study first gives a single dose to healthy adults, then multiple doses to people with obesity.
This trial tests a new tablet called MWN109 in healthy adults to see how safe it is and how the body handles it. It has two parts: one for people with a wide range of body weights, and another specifically for people with higher body weight. The results will help guide future studies.
Hear when a new Chronic Weight Management trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.